Procept rises after lifting annual revenue forecast, upbeat quarter

PROCEPT BioRobotics

28/10/2024 11:31

** Shares of Procept BioRobotics  PRCT.O  rise 16.4% to
$80.04 premarket
    ** Medical device maker raises its 2024 rev. forecast to the
range of $222.5 mln to $223 mln vs its previous outlook of $217
mln
    ** Co's Q3 rev. of $58.4 mln beats Wall Street estimates of
$53.2 mln - LSEG
    ** PRCT's Q3 loss of 40 cents/shr is narrower than 51
cents/shr a year ago
    ** Up to last close, stock up 64.1% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))